Page URL:

Revamped CRISPR can edit more locations in the genome

5 March 2018
Appeared in BioNews 940

Scientists have altered the Cas9 enzyme, increasing the number of sites that can be targeted by the CRISPR/Cas9 approach to genome editing.

This finding could increase the number of situations in which CRISPR/Cas9 can be used. Different Cas9 enzymes recognise specific DNA sequences (known as PAM sequences) and can only modify the sites near this sequence. This limitation means that the most commonly used type of Cas9 can only target around one in 16 sites in the genome.

'That's been a real limitation,' said Professor David Liu of Harvard University, Massachusetts, who led the research published in Nature last week. 'If you're trying a CRISPR application that requires very precise positioning of [Cas9] you need to be lucky to have a PAM in just the right place.'

The research team used a method first developed in Professor Liu's lab in 2011 to rapidly evolve Cas9, creating a new variant – xCas9 – that can target around a quarter of the sites in the genome.

'There are numerous efforts to develop CRISPR technologies for clinical and research applications, and we hope that this work increases the likelihood that a particular site of interest is accessible,' explained Professor Liu.

Although they were intending to only broaden the number of PAM sequences that could be targeted, the team found that xCas9 is more precise than other types of the enzyme: an unexpected result, as it was thought that an enzyme that could target more PAM sites would also be less accurate.

'Scientifically, the increased specificity was the biggest shock,' said Professor Liu. It isn't clear yet why xCas9 is more precise. 'If you ask me for a detailed mechanistic explanation for why that is, my answer is, "I don't know".'

'I am amazed that the new Cas9 has both broader PAM recognition and higher specificity,' said Dr Stanley Qi, from Stanford University, California, who was not involved in the study. 'That's amazing biology.'

The full potential of xCas9 as a genome-editing tool will only be clear once it has been tested further: the team tested it on only a few dozen sites in the genome, compared to thousands that the standard Cas9 has been shown to target.

'The hope is that, eventually, we'll have a big bookshelf of Cas9 or other CRISPR enzyme solutions,' says Professor Liu. 'Our efforts in this line of research are never really over until we can access every possible site in the human genome.'

Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Nature |  28 February 2018
Evolving a more versatile CRISPR-Cas9
Broad Institute |  3 March 2018
Powerful enzyme could make CRISPR gene-editing more versatile
Nature News |  28 February 2018
Upgrade makes genome editor CRISPR more muscular, precise
Science |  28 February 2018
28 October 2019 - by Dr Jennifer Frosch 
An improved genome editing method could potentially correct 89 percent of known genetic defects causing disease, US scientists say.
29 October 2018 - by Shaoni Bhattacharya 
Researchers have identified a new enzyme to make the genome editing approach, CRISPR, able to target more locations within the genome...
16 April 2018 - by Lone Hørlyck 
An upgraded version of the CRISPR approach to genome editing has been used for the first time to edit multiple genes at once and assess the effects of editing...
9 October 2017 - by Emma Laycock 
Scientists have repaired the faulty gene in a mouse model of muscular dystrophy by using gold nanoparticles to deliver the genome editing tool CRISPR-Cas9...
10 July 2017 - by Rikita Patel 
Researchers have revealed the structure and action of a new type of 'molecular scissors' known as Cpf1, which may improve CRISPR genome editing.
3 July 2017 - by Dr Dusko Ilic 
Recent debate over the safety of CRISPR-Cas9 genome editing following a study that suggested it can cause hundreds of unexpected mutations left me puzzled...
5 June 2017 - by Charlotte Spicer 
CRISPR may introduce hundreds of unwanted mutations into the genome, a small study finds...
11 January 2016 - by Paul Waldron 
Researchers have improved the genome-editing technique CRISPR/Cas9, reducing errors to nearly undetectable levels, according to a new study...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.